Hantavirus scientists were close to vaccine but ran out of money

Scientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes for a treatment against the rare virus that can spread between people. But the project stalled before human trials due to lack of funding and the Covid-19 pandemic.